Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021

Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021

Abstract Introduction Biomarker testing is increasingly crucial for patients with early-stage non-small cell lung cancer (eNSCLC). We explored biomarker test utilization and subsequent treatment in eNSCLC patients in the real-world setting. Methods Using COTA’s oncology database, this retrospective...

Full description

Bibliographic Details
Main Authors: Jessie T. Yan, Yue Jin, Ernest Lo, Yilin Chen, Amy E. Hanlon Newell, Ying Kong, Landon J. Inge
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-06-01
Series:Oncology and Therapy
Subjects:
Biomarkers
Diagnostic testing
Early-stage
Non-small cell lung cancer
Real-world testing
Online Access:https://doi.org/10.1007/s40487-023-00234-7

Internet

https://doi.org/10.1007/s40487-023-00234-7

Similar Items